Privia Health Group Files 8-K

Ticker: PRVA · Form: 8-K · Filed: 2025-10-28T00:00:00.000Z

Sentiment: neutral

Topics: sec-filing, 8-k

Related Tickers: PRVA

TL;DR

PRVA filed an 8-K on 10/28 for an event on 10/24, no major news.

AI Summary

Privia Health Group, Inc. filed an 8-K on October 28, 2025, reporting an event that occurred on October 24, 2025. The filing is categorized under 'Other Events' and does not specify any material changes or significant transactions.

Why It Matters

This 8-K filing indicates a routine update or event for Privia Health Group, Inc., requiring disclosure to the SEC.

Risk Assessment

Risk Level: low — The filing is a standard 8-K for 'Other Events' without specific details of material impact.

Key Players & Entities

FAQ

What specific event is reported under 'Other Events' in this 8-K filing?

The filing does not specify the nature of the 'Other Events' beyond its categorization.

When was the earliest event reported in this 8-K filing?

The earliest event reported was on October 24, 2025.

On what date was this 8-K form filed with the SEC?

This 8-K form was filed on October 28, 2025.

What is the principal executive office address for Privia Health Group, Inc.?

The principal executive office address is 950 N. Glebe Rd., Suite 700, Arlington, Virginia 22203.

Under which section of the Securities Exchange Act of 1934 is this report filed?

This report is filed pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934.

From the Filing

0001759655-25-000104.txt : 20251028 0001759655-25-000104.hdr.sgml : 20251028 20251028171137 ACCESSION NUMBER: 0001759655-25-000104 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 12 CONFORMED PERIOD OF REPORT: 20251024 ITEM INFORMATION: Other Events FILED AS OF DATE: 20251028 DATE AS OF CHANGE: 20251028 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Privia Health Group, Inc. CENTRAL INDEX KEY: 0001759655 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-HEALTH SERVICES [8000] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-40365 FILM NUMBER: 251425804 BUSINESS ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 BUSINESS PHONE: 571-366-8850 MAIL ADDRESS: STREET 1: 950 N. GLEBE RD., SUITE 700 CITY: ARLINGTON STATE: VA ZIP: 22203 FORMER COMPANY: FORMER CONFORMED NAME: PH Group Parent Corp. DATE OF NAME CHANGE: 20181120 8-K 1 prva-20251024.htm 8-K prva-20251024 0001759655 FALSE 0001759655 2025-10-24 2025-10-24 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 _________________________ FORM 8-K _______________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 24, 2025 _________________________ Privia Health Group, Inc. (Exact Name of Registrant as Specified in Its Charter) _________________________ Delaware 001-40365 81-3599420 (State or other jurisdiction of incorporation or organization) (Commission File No.) (I.R.S. Employer Identification No.) 950 N. Glebe Rd., Suite 700 Arlington, Virginia 22203 (Address of Principal Executive Offices) (Zip Code) ( 571 ) 366-8850 Registrant's telephone number, including area code Not Applicable (Former name, former address and former fiscal year, if changed since last report) Check the appropriate box below if the form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2 (b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol(s) Name of each exchange on which registered Common Stock, $0.01 par value per share PRVA The Nasdaq Global Select Market Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐ Item 8.01. Other Events. On October 24, 2025, Patricia Maryland, a member of the Board of Directors of Privia Health Group, Inc. (the “Company”) and Chair of its Compliance Committee, passed away. The Company is saddened by her death and grateful for her service and meaningful contributions to the Company over the past five years. SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. PRIVIA HEALTH GROUP, INC. Date: October 28, 2025 By: /s/ Parth Mehrotra Name: Parth Mehrotra Title: Chief Executive Officer EX-101.SCH 2 prva-20251024.xsd XBRL TAXON

View on Read The Filing